128 related articles for article (PubMed ID: 8874214)
21. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
[TBL] [Abstract][Full Text] [Related]
22. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.
Coustan-Smith E; Kitanaka A; Pui CH; McNinch L; Evans WE; Raimondi SC; Behm FG; Aricò M; Campana D
Blood; 1996 Feb; 87(3):1140-6. PubMed ID: 8562940
[TBL] [Abstract][Full Text] [Related]
23. Growth of sensitive and drug-resistant human myeloid leukemia cells in SCID mice.
Beran M; Pisa P; Kantarjian H; Porwit A; Bjorkholm M
Hematol Pathol; 1994; 8(4):135-54. PubMed ID: 7860433
[TBL] [Abstract][Full Text] [Related]
24. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
[TBL] [Abstract][Full Text] [Related]
25. Effects of flt3 ligand on acute myeloid and lymphocytic leukemic blast cells from children.
McKenna HJ; Smith FO; Brasel K; Hirschstein D; Bernstein ID; Williams DE; Lyman SD
Exp Hematol; 1996 Feb; 24(2):378-85. PubMed ID: 8641369
[TBL] [Abstract][Full Text] [Related]
26. Dissemination and tissue invasiveness in murine acute leukemia associated with acquisition of p53 mutation and loss of wild-type p53.
Hsiao M; Wu CY; Low J; Pattengale P; Yeargin J; Haas M
Mol Carcinog; 1995 Jun; 13(2):112-21. PubMed ID: 7605579
[TBL] [Abstract][Full Text] [Related]
27. Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome.
Woiterski J; Ebinger M; Witte KE; Goecke B; Heininger V; Philippek M; Bonin M; Schrauder A; Röttgers S; Herr W; Lang P; Handgretinger R; Hartwig UF; André MC
Int J Cancer; 2013 Oct; 133(7):1547-56. PubMed ID: 23526331
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of t(11;19) breakpoints in childhood acute leukemias.
Rubnitz JE; Behm FG; Curcio-Brint AM; Pinheiro RP; Carroll AJ; Raimondi SC; Shurtleff SA; Downing JR
Blood; 1996 Jun; 87(11):4804-8. PubMed ID: 8639852
[TBL] [Abstract][Full Text] [Related]
29. Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice.
Namikawa R; Ueda R; Kyoizumi S
Blood; 1993 Oct; 82(8):2526-36. PubMed ID: 8104540
[TBL] [Abstract][Full Text] [Related]
30. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
[TBL] [Abstract][Full Text] [Related]
31. Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice.
Lapidot T; Grunberger T; Vormoor J; Estrov Z; Kollet O; Bunin N; Zaizov R; Williams DE; Freedman MH
Blood; 1996 Oct; 88(7):2655-64. PubMed ID: 8839860
[TBL] [Abstract][Full Text] [Related]
32. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential.
Cheung AM; Wan TS; Leung JC; Chan LY; Huang H; Kwong YL; Liang R; Leung AY
Leukemia; 2007 Jul; 21(7):1423-30. PubMed ID: 17476279
[TBL] [Abstract][Full Text] [Related]
33. Two serologic markers to monitor the engraftment, growth, and treatment response of human leukemias in severe combined immunodeficient mice.
Arguello F; Sterry JA; Zhao YZ; Alexander MR; Shoemaker RH; Cohen HJ
Blood; 1996 May; 87(10):4325-32. PubMed ID: 8639792
[TBL] [Abstract][Full Text] [Related]
34. Suppression of growth and dissemination in human pre-B leukemia cells by tumor necrosis factor-alpha in scid mice.
Yoshida N; Ishii E; Mohri S; Nagumo F; Yoshidomi S; Miyazaki S
Leuk Lymphoma; 1999 Mar; 33(1-2):107-18. PubMed ID: 10194127
[TBL] [Abstract][Full Text] [Related]
35. Establishment of a karyotypically normal cytotoxic leukemic T-cell line from a T-ALL sample engrafted in SCID mice.
Cesano A; O'Connor R; Nowell PC; Lange B; Clark SC; Santoli D
Blood; 1993 May; 81(10):2714-22. PubMed ID: 8490180
[TBL] [Abstract][Full Text] [Related]
36. Efficient engraftment of primary adult T-cell leukemia cells in newborn NOD/SCID/beta2-microglobulin(null) mice.
Kawano N; Ishikawa F; Shimoda K; Yasukawa M; Nagafuji K; Miyamoto T; Baba E; Tanaka T; Yamasaki S; Gondo H; Otsuka T; Ohshima K; Shultz LD; Akashi K; Harada M
Leukemia; 2005 Aug; 19(8):1384-90. PubMed ID: 15959532
[TBL] [Abstract][Full Text] [Related]
37. Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture.
Terpstra W; Ploemacher RE; Prins A; van Lom K; Pouwels K; Wognum AW; Wagemaker G; Löwenberg B; Wielenga JJ
Blood; 1996 Sep; 88(6):1944-50. PubMed ID: 8822911
[TBL] [Abstract][Full Text] [Related]
38. Childhood acute myeloid leukemia in mice with severe combined immunodeficiency.
Chelstrom LM; Gunther R; Simon J; Raimondi SC; Krance R; Crist WM; Uckun FM
Blood; 1994 Jul; 84(1):20-6. PubMed ID: 8018918
[TBL] [Abstract][Full Text] [Related]
39. Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice.
Ailles LE; Humphries RK; Thomas TE; Hogge DE
Exp Hematol; 1999 Nov; 27(11):1609-20. PubMed ID: 10560908
[TBL] [Abstract][Full Text] [Related]
40. Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice.
Nijmeijer BA; Mollevanger P; van Zelderen-Bhola SL; Kluin-Nelemans HC; Willemze R; Falkenburg JH
Exp Hematol; 2001 Mar; 29(3):322-9. PubMed ID: 11274760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
